LakeShore Biopharma Co (LakeShore Biopharma Co) Long-Term Debt : $49.60 Mil (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Long-Term Debt?

LakeShore Biopharma Co's Long-Term Debt for the quarter that ended in Sep. 2023 was $49.60 Mil.

LakeShore Biopharma Co's quarterly Long-Term Debt increased from Sep. 2022 ($40.46 Mil) to Mar. 2023 ($42.64 Mil) and increased from Mar. 2023 ($42.64 Mil) to Sep. 2023 ($49.60 Mil).

LakeShore Biopharma Co's annual Long-Term Debt increased from Mar. 2021 ($0.17 Mil) to Mar. 2022 ($40.02 Mil) and increased from Mar. 2022 ($40.02 Mil) to Mar. 2023 ($42.64 Mil).

LakeShore Biopharma Co Long-Term Debt Historical Data

The historical data trend for LakeShore Biopharma Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Long-Term Debt Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Long-Term Debt

0.17

40.02

42.64

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Long-Term Debt	Get a 7-Day Free Trial			-	40.02	40.46	42.64	49.60

LakeShore Biopharma Co (NAS:LSB) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

LakeShore Biopharma Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.